Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3232–3239. doi: 10.1128/jcm.35.12.3232-3239.1997

Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis.

C Carrière 1, P F Riska 1, O Zimhony 1, J Kriakov 1, S Bardarov 1, J Burns 1, J Chan 1, W R Jacobs Jr 1
PMCID: PMC230153  PMID: 9399525

Abstract

TM4 is a lytic mycobacteriophage which infects mycobacteria of clinical importance. A luciferase reporter phage, phAE40, has been constructed from TM4 and was previously shown to be useful for the rapid detection and drug susceptibility testing of Mycobacterium tuberculosis. However, the lytic nature of the phage results in a loss of detectable light output and limits the sensitivity of detection. We describe several strategies aimed at improving the luciferase activity generated by TM4 luciferase phages, including (i) varying the position of the luciferase gene in the phage genome, (ii) isolating host-range mutants of the phage, and (iii) introducing temperature-sensitive mutations in the phage such that it will not replicate at the infecting temperature. Several new phages generated by these methods show increased intensity of luciferase production compared to the first-generation reporter phage phAE40, and one phage, phAE88, also demonstrates an enhanced duration of luciferase activity. This has allowed the detection of as few as 120 BCG cells and the determination of drug susceptibilities of M. tuberculosis in as little as 1 day.

Full Text

The Full Text of this article is available as a PDF (360.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balasubramanian V., Pavelka M. S., Jr, Bardarov S. S., Martin J., Weisbrod T. R., McAdam R. A., Bloom B. R., Jacobs W. R., Jr Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol. 1996 Jan;178(1):273–279. doi: 10.1128/jb.178.1.273-279.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chaudhuri B., Sau S., Datta H. J., Mandal N. C. Isolation, characterization, and mapping of temperature-sensitive mutations in the genes essential for lysogenic and lytic growth of the mycobacteriophage L1. Virology. 1993 May;194(1):166–172. doi: 10.1006/viro.1993.1246. [DOI] [PubMed] [Google Scholar]
  3. Collins F. M. Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome. Clin Microbiol Rev. 1989 Oct;2(4):360–377. doi: 10.1128/cmr.2.4.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Donnelly-Wu M. K., Jacobs W. R., Jr, Hatfull G. F. Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol Microbiol. 1993 Feb;7(3):407–417. doi: 10.1111/j.1365-2958.1993.tb01132.x. [DOI] [PubMed] [Google Scholar]
  5. Hatfull G. F., Sarkis G. J. DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics. Mol Microbiol. 1993 Feb;7(3):395–405. doi: 10.1111/j.1365-2958.1993.tb01131.x. [DOI] [PubMed] [Google Scholar]
  6. Hobby G. L., Holman A. P., Iseman M. D., Jones J. M. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 1973 Aug;4(2):94–104. doi: 10.1128/aac.4.2.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jacobs W. R., Jr, Barletta R. G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G. J., Hatfull G. F., Bloom B. R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 1993 May 7;260(5109):819–822. doi: 10.1126/science.8484123. [DOI] [PubMed] [Google Scholar]
  8. Jacobs W. R., Jr, Snapper S. B., Tuckman M., Bloom B. R. Mycobacteriophage vector systems. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S404–S410. doi: 10.1093/clinids/11.supplement_2.s404. [DOI] [PubMed] [Google Scholar]
  9. Jacobs W. R., Jr, Tuckman M., Bloom B. R. Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature. 1987 Jun 11;327(6122):532–535. doi: 10.1038/327532a0. [DOI] [PubMed] [Google Scholar]
  10. Levin M. E., Hatfull G. F. Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol Microbiol. 1993 Apr;8(2):277–285. doi: 10.1111/j.1365-2958.1993.tb01572.x. [DOI] [PubMed] [Google Scholar]
  11. Pearson R. E., Jurgensen S., Sarkis G. J., Hatfull G. F., Jacobs W. R., Jr Construction of D29 shuttle phasmids and luciferase reporter phages for detection of mycobacteria. Gene. 1996 Dec 12;183(1-2):129–136. doi: 10.1016/s0378-1119(96)00530-6. [DOI] [PubMed] [Google Scholar]
  12. Raviglione M. C., Snider D. E., Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995 Jan 18;273(3):220–226. [PubMed] [Google Scholar]
  13. Riska P. F., Jacobs W. R., Jr, Bloom B. R., McKitrick J., Chan J. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol. 1997 Dec;35(12):3225–3231. doi: 10.1128/jcm.35.12.3225-3231.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sarkis G. J., Jacobs W. R., Jr, Hatfull G. F. L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria. Mol Microbiol. 1995 Mar;15(6):1055–1067. doi: 10.1111/j.1365-2958.1995.tb02281.x. [DOI] [PubMed] [Google Scholar]
  15. Snapper S. B., Melton R. E., Mustafa S., Kieser T., Jacobs W. R., Jr Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol. 1990 Nov;4(11):1911–1919. doi: 10.1111/j.1365-2958.1990.tb02040.x. [DOI] [PubMed] [Google Scholar]
  16. Snider D. E., Jr, Dooley S. W. Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease. Heart Lung. 1993 Jul-Aug;22(4):365–369. [PubMed] [Google Scholar]
  17. Stover C. K., de la Cruz V. F., Fuerst T. R., Burlein J. E., Benson L. A., Bennett L. T., Bansal G. P., Young J. F., Lee M. H., Hatfull G. F. New use of BCG for recombinant vaccines. Nature. 1991 Jun 6;351(6326):456–460. doi: 10.1038/351456a0. [DOI] [PubMed] [Google Scholar]
  18. Timme T. L., Brennan P. J. Induction of bacteriophage from members of the Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium scrofulaceum serocomplex. J Gen Microbiol. 1984 Aug;130(8):2059–2066. doi: 10.1099/00221287-130-8-2059. [DOI] [PubMed] [Google Scholar]
  19. Turett G. S., Telzak E. E., Torian L. V., Blum S., Alland D., Weisfuse I., Fazal B. A. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis. 1995 Nov;21(5):1238–1244. doi: 10.1093/clinids/21.5.1238. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES